- call +1-201-465-4211
- email sales@mrinsights.biz
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
There are three type of insulin by resource, it is animal insulin, human insulin, insulin analogue. Animal insulin, because of its side effects, the market share of it is less than 10%, and in the future, the market share will be decrease continually. Human insulin has a larger consumption than insulin analogue, but the side effect is bigger than insulin analogue, so the future market will be occupied by insulin analogue. At the same time, the biggest company producing insulin, Novo Nordisk, has developed a new kind insulin recently, so it will also has a market share in the future.
According to this study, over the next five years the Insulin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin market by product type, application, key manufacturers and key regions and countries.
This study considers the Insulin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Animal Insulin
Regular Human Insulin
Insulin Analogue
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Insulin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Insulin market by identifying its various subsegments.
Focuses on the key global Insulin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Insulin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Insulin Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Consumption 2014-2024
2.1.2 Insulin Consumption CAGR by Region
2.2 Insulin Segment by Type
2.2.1 Animal Insulin
2.2.2 Regular Human Insulin
2.2.3 Insulin Analogue
2.3 Insulin Consumption by Type
2.3.1 Global Insulin Consumption Market Share by Type (2014-2019)
2.3.2 Global Insulin Revenue and Market Share by Type (2014-2019)
2.3.3 Global Insulin Sale Price by Type (2014-2019)
2.4 Insulin Segment by Application
2.4.1 Short acting
2.4.2 Intermediate acting
2.4.3 Long acting
2.4.4 Pre-mix Insulin
2.5 Insulin Consumption by Application
2.5.1 Global Insulin Consumption Market Share by Application (2014-2019)
2.5.2 Global Insulin Value and Market Share by Application (2014-2019)
2.5.3 Global Insulin Sale Price by Application (2014-2019)
3 Global Insulin by Players
3.1 Global Insulin Sales Market Share by Players
3.1.1 Global Insulin Sales by Players (2017-2019)
3.1.2 Global Insulin Sales Market Share by Players (2017-2019)
3.2 Global Insulin Revenue Market Share by Players
3.2.1 Global Insulin Revenue by Players (2017-2019)
3.2.2 Global Insulin Revenue Market Share by Players (2017-2019)
3.3 Global Insulin Sale Price by Players
3.4 Global Insulin Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Insulin Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Insulin by Regions
4.1 Insulin by Regions
4.1.1 Global Insulin Consumption by Regions
4.1.2 Global Insulin Value by Regions
4.2 Americas Insulin Consumption Growth
4.3 APAC Insulin Consumption Growth
4.4 Europe Insulin Consumption Growth
4.5 Middle East & Africa Insulin Consumption Growth
5 Americas
5.1 Americas Insulin Consumption by Countries
5.1.1 Americas Insulin Consumption by Countries (2014-2019)
5.1.2 Americas Insulin Value by Countries (2014-2019)
5.2 Americas Insulin Consumption by Type
5.3 Americas Insulin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Insulin Consumption by Countries
6.1.1 APAC Insulin Consumption by Countries (2014-2019)
6.1.2 APAC Insulin Value by Countries (2014-2019)
6.2 APAC Insulin Consumption by Type
6.3 APAC Insulin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Insulin by Countries
7.1.1 Europe Insulin Consumption by Countries (2014-2019)
7.1.2 Europe Insulin Value by Countries (2014-2019)
7.2 Europe Insulin Consumption by Type
7.3 Europe Insulin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Insulin by Countries
8.1.1 Middle East & Africa Insulin Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Insulin Value by Countries (2014-2019)
8.2 Middle East & Africa Insulin Consumption by Type
8.3 Middle East & Africa Insulin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Insulin Distributors
10.3 Insulin Customer
11 Global Insulin Market Forecast
11.1 Global Insulin Consumption Forecast (2019-2024)
11.2 Global Insulin Forecast by Regions
11.2.1 Global Insulin Forecast by Regions (2019-2024)
11.2.2 Global Insulin Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Insulin Forecast by Type
11.8 Global Insulin Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Details
12.1.2 Insulin Product Offered
12.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk News
12.2 Eli Lilly
12.2.1 Company Details
12.2.2 Insulin Product Offered
12.2.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Eli Lilly News
12.3 Sanofi-Aventis
12.3.1 Company Details
12.3.2 Insulin Product Offered
12.3.3 Sanofi-Aventis Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Sanofi-Aventis News
12.4 Tonghua Dongbao
12.4.1 Company Details
12.4.2 Insulin Product Offered
12.4.3 Tonghua Dongbao Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Tonghua Dongbao News
12.5 Ganlee
12.5.1 Company Details
12.5.2 Insulin Product Offered
12.5.3 Ganlee Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Ganlee News
12.6 United Laboratory
12.6.1 Company Details
12.6.2 Insulin Product Offered
12.6.3 United Laboratory Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 United Laboratory News
12.7 Jiangsu Wanbang
12.7.1 Company Details
12.7.2 Insulin Product Offered
12.7.3 Jiangsu Wanbang Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Jiangsu Wanbang News
...
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Insulin
Table Product Specifications of Insulin
Figure Insulin Report Years Considered
Figure Market Research Methodology
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
